THE SCIENCE

Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) corresponding to the first 29 amino acids of human GHRH. Research has examined its ability to stimulate the pituitary gland to release growth hormone through the GHRH pathway.

MOLECULAR STRUCTURE

Sermorelin is a 29-amino-acid peptide based on the N-terminal portion of human GHRH. Its structure allows it to interact with the GHRH receptor and reproduce key biological activity of endogenous GHRH

GHRH RECEPTOR ACTIVITY

Sermorelin acts through the GHRH receptor pathway, stimulating growth hormone secretion from pituitary somatotroph cells. Human studies of GHRH(1-29) have demonstrated measurable increases in circulating growth hormone following administration.

GROWTH HORMONE & IGF-1

Growth hormone released through GHRH signaling can influence downstream insulin-like growth factor-1 (IGF-1) production. Clinical research involving GHRH(1-29) has examined changes in growth hormone secretion and IGF-1 in children with growth hormone deficiency and other growth-related conditions.

GROWTH & BODY COMPOSITION

Research involving GHRH(1-29) has examined growth and body-composition-related outcomes. Clinical studies have primarily focused on growth hormone deficiency and growth disorders, while other research has examined the broader effects of GHRH stimulation on the growth hormone axis.

CLINICAL RESEARCH

Sermorelin and GHRH(1-29) have been studied in human clinical research, including investigations of growth hormone secretion and growth in children with growth hormone deficiency. The U.S. FDA records that sermorelin acetate (Geref) received marketing approval in 1997 for an indication involving idiopathic or organic growth hormone deficiency in children with growth failure

PRECLINICAL RESEARCH

The available evidence for KPV is predominantly preclinical. Findings from cell and animal studies should be interpreted according to the experimental model, study design, and specific endpoints measured and should not automatically be assumed to demonstrate the same effects in humans